| Name | MAGI2 antisense RNA 2 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n This study demonstrates that the long non‐coding RNA MAGI2‐AS3 is significantly downregulated in non‐small cell lung cancer (NSCLC) tissues and cell lines, suggesting a tumor‐suppressive function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Functional assays—including CCK-8, EdU, colony formation, and Transwell migration/invasion tests—revealed that overexpression of MAGI2‐AS3 markedly inhibits NSCLC cell proliferation, migration, and invasion. Mechanistically, MAGI2‐AS3 exerts its tumor‐suppressive effects by modulating the miR-629-5p/TXNIP axis, thereby dampening pro-oncogenic signaling pathways. In vivo experiments using a nude mice model further confirmed its inhibitory effect on tumor progression. These findings highlight the potential of MAGI2‐AS3 as a promising therapeutic target in NSCLC."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jun Gong, Lei Ma, Chunlei Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Transl Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/atm-21-6466"}], "href": "https://doi.org/10.21037/atm-21-6466"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35071487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35071487"}]}]}]}
|
| NCBI Gene ID | 100874021 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MAGI2-AS2 has 176 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.
Click the + buttons to view associations for MAGI2-AS2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAGI2-AS2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAGI2-AS2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MAGI2-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MAGI2-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MAGI2-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MAGI2-AS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAGI2-AS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MAGI2-AS2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |